Shots:
The US FDA has granted conditional approval to initiate the second cohort of the early feasibility study (EFS) of the Aeson artificial heart in the US by H2’25, pending ethics committee approval & personnel training; launch expected by 2028
EFS is being conducted in 2 cohorts; first (n=3) was completed in Q3’21, leading to FDA-approved…
